Smart Money Alert

Bio Medica Lab

Newly DisclosedQuarterly

BMLLPharmaceuticalsMarket Cap₹154 Cr

Disclosed stake

2.07%

Holding

2.60 L shares

As of

Sept 2026

Since alert−5.8%₹155.50 → ₹146.40

Nifty 50−0.6%

Pine Oak

Foreign Investor

The move

Pine Oak holds 2,60,000 shares of Bio Medica Lab, translating to a 2.07% stake, as disclosed in the company's first shareholding filing since listing.

About Bio Medica Lab

+ Follow Visit stock

Bio Medica Laboratories manufactures pharmaceutical parenteral formulations, specializing in generic injectable drugs for human and veterinary use. Founded in August 2015 and headquartered in Indore, Madhya Pradesh, the company operates a contract manufacturing business with a portfolio of 58 liquid injectables and 15 dry powder injectables. The company listed on the NSE SME platform in May 2026.

About Pine Oak

+ Follow Visit investor

Pine Oak Global Fund is a foreign portfolio investor that acts as an anchor investor in Indian SME IPOs. It has invested across sectors such as logistics, textiles, infrastructure, pharmaceuticals, and solar.

Get the next move the moment it happens.

Follow Pine Oak and Bio Medica Lab on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Bio Medica Lab shareholders Pine Oak's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Bio Medica Lab

Moneyplant Gold & Jewellery TradingNew position

Moneyplant Gold & Jewellery Trading bought 2,10,000 shares of Bio Medica Lab for ₹2.67 Cr at ₹127.17 apiece in a bulk deal.

10 Jun 2026